-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Biogen, Raises Price Target to $156

Benzinga·12/12/2025 17:07:06
Listen to the news
Morgan Stanley analyst Matthew Harrison maintains Biogen (NASDAQ:BIIB) with a Equal-Weight and raises the price target from $149 to $156.